A Look At The Varied Career Of Entrepreneur Arthur Becker

Arthur Becker is a notable entrepreneur who made his fortune in the financial and biotech industries. He is now a real estate and technology investor with over $500 million invested in real estate projects in the city of New York as well as other properties in Miami. Arthur Becker is also a lifelong artist and displays some of his pieces of art at his offices in the Soho district. In addition to displaying his art at his Madison Partners offices, Arthur Becker’s work has also been displayed at art studios in both New York and Florida. More details can be found on Crunchbase.com

Just down the street from his offices, Arthur Becker is the sole investor in a luxury condo project that is currently being built. Once completed, the project will be worth $52.5 million and will have eight luxury condos. He also recently completed another real estate deal where in exchange for his interest in a project that is building a luxury condo building, he got ownership of three adjacent high-end townhomes. He plans to live in one of the units, on which he is investing $20 million in improvements, and is deciding whether to sell or rent the other two properties.

Arthur Becker has had a varied career. He started out managing a macadamia nut farm in Hawaii. He has also been a stockbroker for Bear Stearns. He made a huge amount of money by buying tech companies in the early 2000’s after many of the companies values had dramatically fallen after the market crash of 1999. He has also been a senior advisor to the fashion designer Vera Wang, to whom he was married before they separated in 2012. He has also been the top executive at two tech companies, Zinio, LLC and NaviSite.

In an article on The Real Deal, it is through his investment firm, Madison Partners, LLC that Becker invests in real estate and biotech companies. As the Managing Partner, he selects what he is going to invest his money in. His investment in biotech companies specializes in startups in the industry with a focus on those developing cures for cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *